Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

RTTNews | 339 दिनों पहले
Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

(RTTNews) - Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

The nearly 300,000-square-foot facility will employ 400 full-time staff. It also features open workspaces to foster collaboration and has been designed to meet the highest environmental sustainability standards, in support of Amgen's commitment to achieve carbon neutrality for all operations by 2027.

In partnership with Columbus State Community College, Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site. This program, designed for those new to the field or changing careers, offers a blend of classroom and practical training, aiming to expand opportunities for skilled individuals without the requirement for a formal bachelor's degree.

टैग: AMGN
read more
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...
RTTNews | 246 दिनों पहले
Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
RTTNews | 891 दिनों पहले
European Shares Extend Gains On ECB's Dovish Outlook

European Shares Extend Gains On ECB's Dovish Outlook

European stocks hit new record highs on Friday, a day after the European Central Bank delivered a widely expected 25-basis point interest-rate cut and guided for a further reduction in March due to concerns about economic growth.
RTTNews | 5घंटे 11 मिनट पहले
Yen Rises Amid Tariff Worries

Yen Rises Amid Tariff Worries

The Japanese yen strengthened against other major currencies in the Asian session on Friday, as investor sentiment dropped on the sidelines after U.S. President Donald Trump announced that 25 percent tariffs on Canada and Mexico are coming on Saturday, although crude flows may be exempted from the levies.
RTTNews | 5घंटे 34 मिनट पहले
Apple Stock Gains On Upbeat Q1, Positive Outlook, Despite Weak IPhone, China Sales

Apple Stock Gains On Upbeat Q1, Positive Outlook, Despite Weak IPhone, China Sales

Apple Inc.'s shares gained more than 3 percent in the after-hours trading on Thursday after the tech major reported higher profit in its first quarter, above market estimates, with strong growth in net sales. This was despite weakness in iPhone and Wearables sales, as well as in China. The company also declared a cash dividend. Further, in its first-quarter earnings call, Apple said it expects...
RTTNews | 7घंटे 20 मिनट पहले